12,206 Shares in Cigna Group $CI Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd bought a new stake in shares of Cigna Group (NYSE:CI) during the first quarter, HoldingsChannel reports. The institutional investor bought 12,206 shares of the health services provider’s stock, valued at approximately $3,256,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Wilkerson Advisory Group LLC bought a new position in Cigna Group during the 4th quarter worth about $25,000. Beacon Financial Strategies CORP acquired a new stake in Cigna Group in the 4th quarter valued at $28,000. Kemnay Advisory Services Inc. bought a new stake in Cigna Group during the 4th quarter worth about $29,000. Prosperity Bancshares Inc bought a new stake in Cigna Group during the 4th quarter worth about $29,000. Finally, Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group during the 4th quarter worth about $32,000. 86.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have commented on CI shares. Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $310.00 to $304.00 in a research note on Tuesday, May 26th. The Goldman Sachs Group lifted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Robert W. Baird set a $337.00 price target on Cigna Group in a report on Friday, May 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, Jefferies Financial Group decreased their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

Cigna Group Price Performance

Shares of Cigna Group stock traded up $5.61 during midday trading on Tuesday, hitting $287.59. 264,404 shares of the company traded hands, compared to its average volume of 1,683,603. The stock has a market cap of $76.08 billion, a price-to-earnings ratio of 12.22, a PEG ratio of 1.11 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm’s fifty day moving average price is $285.09 and its 200-day moving average price is $279.26. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Thursday, June 4th. Cigna Group’s payout ratio is 26.45%.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.